Dr Jeremy Chataway MA, PhD, FRCP Consultant Neurologist National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, University College Foundation NHS Trust and Reader in Neurology, University College London.
After qualifying in medicine at Cambridge and Oxford Universities, and general medical training in London, he specialised in Neurology over an 8 year period with posts in Edinburgh, Cambridge and London. He was awarded a PhD from Cambridge University in genetic epidemiology of multiple sclerosis and took up his post as a consultant Neurologist in 2001 at The National Hospital for Neurology and Neurosurgery, Queen Square, University College Foundation NHS Trust, London.
He is the clinical lead of the MS group at the National Hospital (about 3000 patients) and was a member of the 2014 MS NICE panel. He has a particular interest in clinical trial design and was the Chief Investigator (CI) of the MS-STAT1 trial in secondary progressive MS, using high dose simvastatin; and is the CI of the MS-SMART and MS-STAT2 trials in secondary progressive MS. He is the Clinical Director of the UCL Comprehensive Clinical Trials Unit.